Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.300
-0.020 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
3.530
+0.230 (6.97%)
After-hours: Apr 28, 2026, 6:32 PM EDT
Biodexa Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2 | 2 | 2 | 7 | 4 | 13 | |
| Market Cap Growth | -52.82% | -19.05% | -66.48% | 78.13% | -68.73% | -43.85% | |
| Enterprise Value | -9 | -3 | -4 | 1 | -3 | 8 | |
| Last Close Price | 3.30 | 11.35 | 202.50 | 3350.00 | 394000.00 | 2100000.00 | |
| PS Ratio | - | - | - | 14.46 | 4.68 | 16.10 | |
| PB Ratio | 0.10 | 0.12 | 0.23 | 1.18 | 1.03 | 0.89 | |
| P/TBV Ratio | 0.28 | 0.25 | 0.70 | 3.17 | 1.04 | 0.89 | |
| EV/Sales Ratio | - | - | - | 2.20 | - | 10.11 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.09 | 0.10 | 0.20 | 0.07 | |
| Net Debt / Equity Ratio | -0.74 | -0.74 | -0.11 | -1.18 | -0.70 | -0.89 | |
| Net Debt / EBITDA Ratio | 0.99 | 0.99 | 0.10 | 0.70 | 0.25 | 1.37 | |
| Net Debt / FCF Ratio | 1.52 | 1.52 | 0.08 | 0.80 | 0.31 | 1.47 | |
| Asset Turnover | - | - | - | 0.05 | 0.08 | 0.05 | |
| Quick Ratio | 1.43 | 1.43 | 0.47 | 1.20 | 2.27 | 6.06 | |
| Current Ratio | 2.03 | 2.03 | 1.75 | 1.26 | 2.47 | 6.39 | |
| Return on Equity (ROE) | -64.72% | -64.72% | -88.14% | -180.59% | -112.47% | -63.60% | |
| Return on Assets (ROA) | -32.79% | -32.79% | -45.41% | -62.35% | -60.55% | -38.48% | |
| Return on Capital Employed (ROCE) | -71.70% | -71.70% | -94.40% | -161.20% | -246.40% | -63.20% | |
| Earnings Yield | -401.61% | -451.26% | -304.91% | -128.48% | -234.13% | -58.68% | |
| FCF Yield | -353.55% | -395.35% | -653.04% | -124.36% | -217.43% | -68.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.